Methallylescaline
Chemical compound From Wikipedia, the free encyclopedia
4-methylallyloxy-3,5-dimethoxyphenethylamine (more commonly known as methallylescaline, and abbreviated as MAL) is a lesser-known psychedelic drug. It is the 4-methyl analog of allylescaline. MAL was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 40–65 mg, and the duration is listed as 12–16 hours.[2] Little data exists about the pharmacological properties, metabolism, and toxicity of MAL. The effects of MAL are comparable to that of other mescaline analogs, although with a longer duration. MAL has been sold as a designer drug.[3][4]
![]() | |
Names | |
---|---|
Preferred IUPAC name
2-{3,5-Dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethan-1-amine | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C14H21NO3 | |
Molar mass | 251.326 g·mol−1 |
Pharmacology | |
Legal status | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Legal status
Sweden
Methallylescaline is illegal in Sweden as of 26 January 2016.[5]
United States
Methallylescaline is not directly scheduled under the Controlled Substances Act. However, due to its structural similarities with mescaline, it could potentially be prosecuted under the Federal Analogue Act if sold for human consumption.
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.